You are here

Article info

Article menu
Oncolytic and local immunotherapy
Original research
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer

Authors

Citation

Brito Baleeiro R, Liu P, Chard Dunmall LS, et al
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
Journal for ImmunoTherapy of Cancer 2023;11:e007336. doi: 10.1136/jitc-2023-007336
Online issue publication 
August 16, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.